RxDoctor Payments Data

Lindsey Stewart

Psychiatric/Mental Health · Overland Park, KSNPI 1669937884

Payments from drug & device makers

$806in general payments, 2019–2025

Across 31 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$213
  • Johnson & Johnson$169
  • Axsome Therapeutics, Inc.$145
  • AbbVie$129
  • Vanda Pharmaceuticals Inc.$51
  • Teva Pharmaceuticals USA, Inc.$42
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$806 in reported general payments places this provider in the 55th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$388
Medicare patients
17
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl62$85,932
RexultiBrexpiprazole26$40,816
Abilify MaintenaAripiprazole12$32,618
BelsomraSuvorexant13$5,277
Vilazodone Hcl30$2,231
Paliperidone ErPaliperidone16$1,580
Olanzapine59$1,314
Buspirone Hcl138$1,149
Duloxetine Hcl111$884
Aripiprazole86$789
Sertraline Hcl134$774
Desvenlafaxine Succinate ErDesvenlafaxine Succinate34$731
Clozapine11$700
Hydroxyzine Hcl49$694
Trazodone Hcl99$509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$129$85,93262 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$14$73,43438 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →